Download PDF
Thromb Haemost 1985; 53(01): 130-133
DOI: 10.1055/s-0038-1661252
Original Article
Schattauer GmbH Stuttgart

Changes in Plasminogen Activator Activity and Plasmin Inhibition in the Pig During Experimental Hypovolaemia

A Smokovitis
1   The Department of Physiology, Veterinary Faculty, Aristotelian University of Thessaloniki, Greece
,
M Wagner
2   The First Department of Traumatology, Medical School, University of Vienna, Austria
,
M Starlinger
3   The First Department of Surgery, Medical School, University of Vienna, Austria
,
A Opitz
2   The First Department of Traumatology, Medical School, University of Vienna, Austria
,
B R Binder
4   The Department of Medical Physiology, Medical School, University of Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 10 September 1984

Accepted 04 December 1984

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

A markedly decreased plasminogen activator activity (PAA) was seen in lung, heart and kidney after experimental hypovolemia in the pig. In 2 of 12 cases, an increased PAA was found in liver and spleen. In skeletal muscle, skin, sciatic nerve and in 10 of 12 cases in liver and spleen PAA was unchanged. A slightly increased plasmin inhibition was noted only in the lung. These changes in tissue PAA were reflected by an increase in the PAA of euglobulin fractions concomitant with a decrease in antiplasmin activity in the blood samples obtained during the bleeding experiments.

Key words

Haemorrhagic hypotension - Fibrinolysis - Plasminogen activator activity - Plasmin inhibition - Pig
 

  • References

  • 1 Hardaway RM, Johnson DG. Influence of fibrinolysin on shock. JAMA 1963; 183: 597-599
    PubMedGoogle Scholar
  • 2 Kottinen YP. Fibrinolysis: chemistry, physiology, pathology, and clinics. Oy Star Ab; Finland: 1968. p 330
    Google Scholar
  • 3 Büsing CM, Bleyl U. Plasminogen activator activity of pulmonary vessels in shock. Thromb Res 1977; 11: 285-295
    CrossrefPubMedGoogle Scholar
  • 4 Rammer L, Saldeen T. Inhibition of fibrinolysis in post-traumatic death. Thrombos Diathes Haemorrh 1970; 24: 68-75
    PubMedGoogle Scholar
  • 5 Risberg B, Peterson HI. Pulmonary tissue fibrinolysis after drum trauma. An experimental study in the rat Circ Shock 1976; 3: 153-159
    PubMedGoogle Scholar
  • 6 Brakman P, Albrechtsen OK, Astrup T. A comparative study of coagulation and fibrinolysis in blood from normal men and women. Br J Haematol 1966; 12: 74-85
    CrossrefPubMedGoogle Scholar
  • 7 Binder BR, Spragg J, Austen KF. Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. J Biol Chem 1979; 254: 1998-2003
    PubMedGoogle Scholar
  • 8 Teger-Nilsson A-C, Friberger P, Gyzander E. Determination of a new rapid antiplasmin in human blood by using a plasmin specific tripeptide substrate. Scand J Clin Lab Invest 1977; 37: 403-409
    CrossrefPubMedGoogle Scholar
  • 9 Smokovitis A. Normal liver actually possesses a high vascular plasminogen activator activity. Experientia 1979; 35: 776-777
    CrossrefPubMedGoogle Scholar
  • 10 Smokovitis A. Comparative histochemical studies on fibrinolysis in whole organs and isolated tissue layers. Thromb Haemostas 1979; 42: 909-923
    PubMedGoogle Scholar
  • 11 Smokovitis A, Maier M, Binder BR. Comparison between vascular plasminogen activator activity and changes in blood flow in the renal cortex in pigs. Thromb Haemostas 1984; 51: 150-153
    PubMedGoogle Scholar
  • 12 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin J Biol Chem 1982; 257: 2912-2919
    PubMedGoogle Scholar
  • 13 Wiman B, Chmielewska J, Ranby M. Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor J Biol Chem 1984; 259: 3644-3647
    PubMedGoogle Scholar
  • 14 Loskutoff DJ, Van Mourik JA, Erickson LA, Lawrence D. Detection of an usually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci 1983; 80: 2956
    CrossrefPubMedGoogle Scholar
  • 15 Rothe CF. Heart failure and fluid loss in hemorrhagic shock. Fed Proc 1970; 29: 1854-1860
    PubMedGoogle Scholar
  • 16 Altura BM, Halevy S. Beneficial and detrimental actions of histamine H1- and H2-receptor antagonists in circulatory shock. Proc Natl Acad Sci USA 1978; 75: 2941-2944
    CrossrefPubMedGoogle Scholar
  • 17 Famebo LO, Hallman H, Hamberger B, Jonsson G. Catecholamines and haemorrhagic shock in awake und anesthetized rats. Circ Shock 1979; 6: 109-118
    PubMedGoogle Scholar
  • 18 McNeill JR, Stark RD, Greenway CV. Intestinal vasoconstriction after haemorrhage: roles of vasopressin and angiotensin. Am J Physiol 1970; 219: 1342-1347
    CrossrefPubMedGoogle Scholar
  • 19 Selkurt EE. Status of investigative aspects of hemorrhagic shock. Fed Proc 1970; 29: 1832-1835
    PubMedGoogle Scholar
  • 20 Trachte GJ, Lefer AM. Effect of angiotensin II receptor blockade by (Sar1-Ala8) angiotensin II in hemorrhagic shock. Am J Physiol 1979; 236: H280-H285
    PubMedGoogle Scholar
  • 21 Lefer AM. Properties of cardioinhibitory factors produced in shock. Fed Proc 1978; 37: 2734-2740
    PubMedGoogle Scholar
  • 22 Ali SY, Lack CH. Studies on the tissue activator of plasminogen. Biochem J 1965; 96: 63-74
    CrossrefPubMedGoogle Scholar
  • 23 Beard EL, Montouri MH, Danos GJ, Busuttil RW. Plasminogen activator activity of rat lysosomes. Proc Soc Exp Biol Med 1968; 129: 804-808
    CrossrefPubMedGoogle Scholar
  • 24 Beard EL, Busuttil RW, Gottshalk SK. Stress induced release of plasminogen activator from lysosomes. Thrombos Diathes Haemorrh 1969; 21: 20-25
    PubMedGoogle Scholar
  • 25 Lack CH, Ali SY. Tissue activator of plasminogen. Nature 1964; 201: 1030-1031
    CrossrefPubMedGoogle Scholar
  • 26 Holemans R. Enhancement of fibrinolysis in the dog by injection of vasoactive drugs. Am J Physiol 1965; 208: 511-520
    PubMedGoogle Scholar
  • 27 Bernik MB, Oller EP. Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. J Clin Invest 1973; 52: 823-834
    CrossrefPubMedGoogle Scholar
  • 28 McNicol GP, Douglas AS. The fibrinolytic enzyme system. In Human blood coagulation, haemostasis and thrombosis. Biggs R. (Ed) Blackwell Scientific Publ; London: 1976. p 414
    Google Scholar
  • 29 Carriere S, Thorbum GD, O’Morchoe CC C, Barger AC. Intrarenal distribution of blood flow in dogs during haemorrhagic hypotension. Circ Res 1966; 19: 167-179
    CrossrefPubMedGoogle Scholar
  • 30 Passmore JC, Leffler CW, Neiberger RE. A critical analysis of renal blood flow distribution during hemorrhage in dogs. Circ Shock 1978; 5: 327-338
    PubMedGoogle Scholar
  • 31 Rector JB, Stein JH, Bay WH, Osgood RW, Ferris TF. Effect of haemorrhage and vasopressor agents on distribution of renal blood flow. Am J Physiol 1972; 222: 1125-1131
    PubMedGoogle Scholar
  • 32 Grega GJ, Daugherty Jr RM, Scott JB, Radawski DP, Haddy FJ. Effect of pressure, flow, and vasoactive agents on vascular resistance and capillary filtration in canine fetal, newborn, and adult lung. Microvasc Res 1971; 3: 297-307
    CrossrefPubMedGoogle Scholar
  • 33 Wiegman DL, Harris PD, Miller FN, Morff RJ, Wilmoth FR. Survival and microvascular responses to hemorrhage with three anesthetic combinations. Am J Physiol 1978; 235: H753-H758
    PubMedGoogle Scholar
  • 34 Rosing DR, Redwood DR, Brakman P, Astrup T, Epstein SE. The fibrinolytic response of man to vasoactive drugs measured in arterial blood. Thromb Res 1978; 13: 419-428
    CrossrefPubMedGoogle Scholar
  • 35 Jedrychowski A, Parbhoo SP, Hillenbrand P. Plasminogen activator in bile during extracorporeal perfusion of pig liver. Gut 1972; 13: 54-57
    CrossrefPubMedGoogle Scholar
  • 36 Losito R, Lemieux E. Streptokinase in the isolated perfused liver. Am J Physiol 1974; 227: 477-481
    PubMedGoogle Scholar
  • 37 Losito R, Gattiker H, Lemieux E, Longre B. Comparative effects of an erythrocyte enriched synthetic replenisher and whole blood on streptokinase activity in the isolated perfused liver. Thromb Res 1979; 14: 125-130
    CrossrefPubMedGoogle Scholar
  • 38 Habal FM, Burrowes CE, Movat HZ. Generation of kinin by plasma kallikrein and plasmin and the effect of alpha-l-antitrypsin and antithrombin III on the kininogenases. In Kinins, Pharmacodynamics and Biological Roles. Sicuteri F, Back N, Haberland GL. (Eds) Plenum Press; New York: 1976. p 23
    Google Scholar
  • 39 Stormorken H. Relation of the fibrinolytic to other biological systems. Thrombos Diathes Haemorrh 1975; 34: 378-385
    PubMedGoogle Scholar
  • 40 Osmond DH, Lo EK, Loh AY, Zingg EA, Hedlin AH. Kallikrein and plasmin as activators of inactive renin. Lancet 1978; 2: 1375-1376
    PubMedGoogle Scholar
  • 41 Bagge L, Saldeen T. The primary fibrinolysis inhibitor and trauma. Thromb Res 1978; 13: 1131-1136
    CrossrefPubMedGoogle Scholar
  • 42 Bagge L, Carlin G, Hjelmstedt A, Högstorp H, Jakobsson H, Modig J, Saldeen T. Fibrinolysis inhibition after a standardized trauma, total hip replacement surgery. Thromb Haemostas 1979; 42: 278 (Abstr.)
    PubMedGoogle Scholar
  • 43 Bergentz SE, Nilsson IM. Effect of trauma on coagulation and fibrinolysis in dogs. Acta Chir Scand 1961; 122: 21-29
    PubMedGoogle Scholar
  • 44 Lindquist O, Bagge L, Saldeen T. Induction of endogenous fibrinolysis inhibition in the dog. Acta Chir Scand 1976; 142: 20-25
    PubMedGoogle Scholar